12:00 AM
 | 
Aug 22, 2011
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Galenica, Hikma Pharmaceuticals sales and marketing update

Galenica's Vifor Pharma Ltd. pharma business granted Hikma exclusive rights to commercialize Ferinject ferric carboxymaltose...

Read the full 63 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >